Eledon Pharmaceuticals (ELDN) Assets Average (2016 - 2017)
Historic Assets Average for Eledon Pharmaceuticals (ELDN) over the last 4 years, with Q3 2017 value amounting to $24.9 million.
- Eledon Pharmaceuticals' Assets Average fell 4033.96% to $24.9 million in Q3 2017 from the same period last year, while for Sep 2017 it was $24.9 million, marking a year-over-year decrease of 4033.96%. This contributed to the annual value of $34.6 million for FY2016, which is 6063.58% down from last year.
- Per Eledon Pharmaceuticals' latest filing, its Assets Average stood at $24.9 million for Q3 2017, which was down 4033.96% from $26.3 million recorded in Q2 2017.
- Over the past 5 years, Eledon Pharmaceuticals' Assets Average peaked at $107.4 million during Q4 2014, and registered a low of $13.5 million during Q1 2017.
- Moreover, its 4-year median value for Assets Average was $57.6 million (2016), whereas its average is $58.1 million.
- As far as peak fluctuations go, Eledon Pharmaceuticals' Assets Average plummeted by 3220.18% in 2015, and later crashed by 7849.61% in 2017.
- Quarter analysis of 4 years shows Eledon Pharmaceuticals' Assets Average stood at $107.4 million in 2014, then tumbled by 32.2% to $72.8 million in 2015, then crashed by 73.95% to $19.0 million in 2016, then skyrocketed by 31.51% to $24.9 million in 2017.
- Its Assets Average was $24.9 million in Q3 2017, compared to $26.3 million in Q2 2017 and $13.5 million in Q1 2017.